How effective is fostatinib? What significant effect does it have during treatment?

Fostamatinib is an oral drug that belongs to a class of drugs called "immunosuppressants" and is mainly used to treat diseases caused by immune system abnormalities, such as idiopathic thrombocytopenic purpura (ITP). It works by inhibiting tyrosine kinase SYK (Spleen tyrosine kinase), blocking abnormal activation of immune cells, thereby reducing the damage to platelets and increasing platelet levels.

In clinical application, fostatinib is mainly used to treat chronic or recurrent ITP in adults, especially those patients who are ineffective in other treatments (such as glucocorticoids, immunoglobulins, etc.). By targeting SYK, fostatinib can reduce immune cell attacks on platelets, thereby slowing or stopping platelet destruction. Patients' platelet counts typically improve significantly within a few weeks of taking fostatinib, which can help reduce bleeding symptoms and improve quality of life.

The significant effects of fostatinib are usually manifested by a short-term increase in platelet counts and improvement in symptoms associated with thrombocytopenia, such as easy bleeding, purpura, and congestion. Fostatinib provides an important treatment option for patients who have failed other treatments, especially when conventional treatments fail to achieve desired results. Studies have shown that a significant proportion of patients taking fostatinib had their platelet counts return to normal or close to normal levels, thus reducing complications from bleeding.
However, the side effects of fostatinib also need to be paid attention to. Common side effects include high blood pressure, diarrhea, nausea and headache. In some cases, more serious side effects such as abnormal liver function or gastrointestinal bleeding may occur, so blood indicators, liver function and blood pressure need to be monitored regularly during use.
In summary, fostatinib, as a targeted therapy for immune system diseases, has shown significant effects in improving platelet counts and reducing bleeding symptoms in ITP patients. However, its side effects also require patients to conduct strict monitoring under the guidance of a doctor when using it.
Reference: https://www.tavalisse.com/